Date
Time

Start time: 12.30 pm

End time: 2.00 pm

Venue
Online: Zoom

Webinar: Prospects for Obesity Medicines

This event is taking place virtually, over Zoom. Click here to read the Zoom user guidance notes.

The recent launches of two highly effective obesity medicines – Wegovy & Mounjaro - have been hugely commercially successful & culturally influential.  Despite these deserved accolades, this presentation will argue these two medicines are likely to have a negligible impact on population mortality.

The presentation will also argue a future wave of potential new obesity medicines could collectively overcome the drawbacks of Wegovy & Mounjaro.  In turn, this future wave could create the potential for a positive impact on future population mortality.

 

Biographical details

Ivor has invested in over 700 listed biotech companies.  As a result, Ivor has significant practical experience in assessing the effectiveness and commercial prospects of potential new medicines.  He has had a long prior career in the life assurance & health insurance industries.  Ivor is a member of the Society’s Healthcare Committee.

Event Type
CPD Event
Event format
Virtual event
Speakers/Presenters
Ivor O’Shea